Whitehawk Therapeutics (WHWK) Shares Outstanding (2010 - 2026)

Whitehawk Therapeutics (WHWK) has 17 years of Shares Outstanding data on file, last reported at $47.2 million in Q1 2026.

• Quarterly Shares Outstanding rose 0.88% year-over-year to $47.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $47.2 million (up 0.88% YoY) and the FY2025 annual result came in at $47.1 million, up 91.02% from the prior year.
• Shares Outstanding steadied at $47.2 million in Q1 2026 per WHWK's latest filing, from $47.1 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $47.2 million in Q1 2026 and bottomed at $20.9 million in Q1 2022.
• The 5-year median for Shares Outstanding is $24.6 million (2023), against an average of $30.7 million.
• The widest annual swing landed in 2022, when Shares Outstanding surged 2753.13%; it then gained 0.36% in 2024.
• Tracing WHWK's Shares Outstanding over 5 years: stood at $24.4 million in 2022, then rose by 0.49% to $24.6 million in 2023, then increased by 0.52% to $24.7 million in 2024, then soared by 91.02% to $47.1 million in 2025, then rose by 0.11% to $47.2 million in 2026.
• Per Business Quant, the three latest WHWK Shares Outstanding figures stand at $47.2 million (Q1 2026), $47.1 million (Q4 2025), and $47.1 million (Q3 2025).

Peer Comparison